Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Ambrx Biopharma Inc ADR (AMAM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2022	12-2021	12-2020	12-2019	12-2017
Cash Flows From Operating Activities
Net Income	-77,996	-68,288	-17,839	-22,313	N/A
Depreciation Amortization	1,293	2,154	1,943	2,053	N/A
Accounts receivable	863	-811	415	-762	N/A
Accounts payable and accrued liabilities	-1,829	2,403	-3,247	3,776	N/A
Other Working Capital	-10,621	3,640	-7,375	14,176	N/A
Other Operating Activity	19,615	16,262	5,527	305	0
Operating Cash Flow	$-68,675	$-44,640	$-20,576	$-2,765	$N/A

Cash Flows From Investing Activities
Change In Deposits	-45,664	N/A	N/A	N/A	N/A
PPE Investments	-1,054	-1,956	-252	-48	N/A
Purchase Sale Intangibles	N/A	-1,250	N/A	N/A	N/A
Other Investing Activity	0	-1,250	0	0	0
Investing Cash Flow	$-46,718	$-3,206	$-252	$-48	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	166,000	N/A	1,339	N/A	N/A
Common Stock Issued	138	148,732	N/A	N/A	N/A
Other Financing Activity	-165,210	-21,305	94,339	0	0
Financing Cash Flow	$928	$127,427	$95,678	$N/A	$N/A

Exchange Rate Effect	N/A	47	165	-38	N/A
Beginning Cash Position	170,906	91,278	16,263	19,114	N/A
End Cash Position	56,441	170,906	91,278	16,263	N/A
Net Cash Flow	$-114,465	$79,628	$75,015	$-2,851	$N/A

Free Cash Flow
Operating Cash Flow	-68,675	-44,640	-20,576	-2,765	N/A
Capital Expenditure	-1,054	-1,956	-252	-48	N/A
Free Cash Flow	-69,729	-46,596	-20,828	-2,813	0